A high-level overview of Amphastar Pharmaceuticals, Inc. (AMPH) stock. View (AMPH) real-time stock price, chart, news, analysis, analyst reviews and more.

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

People with rhinitis or sinusitis or who have chronic congestion are invited to join this 30-minute study, which is testing a novel way to decongest the nose without any medication or invasive procedu ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

Premature babies often need help breathing as their lungs are not fully developed. Nasal breathing support (through the nose) helps premature babies breathe without the need for breathing tubes in the ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

The companies are also running an open-label study to evaluate the long-term efficacy and safety of the therapy.

STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...